Comparative Value of Simple Inflammatory Markers in the Prediction of Left Ventricular Systolic Dysfunction in Postacute Coronary Syndrome Patients

Table 1

Clinical characteristics of the patients according to systolic heart function.

	With LVSD	Without LVSD	𝑃
𝑁	356	404
Age (yrs)	66±14	63±12	.17
Male sex (%)	80	78	.58
BMI (Kg/m^2)	27.5±4	28±5	.14
Systolic blood pressure at entry	128.6±29.2	133.6±26	.013
Diastolic blood pressure at entry	75.5±14	77.4±13	.05
Heart rate at entry	81±16	79±16	.71
Diagnosis MI (%)	84	71	<.0001
Number of Vessel disease	2±0.9	1.8±0.9	<.0001
Previous CHD (%)	49	47	.62
Time delay (min)	548±1953	651±2702	.65
Troponin I at entry	40.28±72.77	16.74±39.43	<.0001
Uric acid (mg/dL)	6.69±2.15	6.14±2.02	<.0001
Blood glucose at entry (mg/dL)	166±89	151±82	.01
CRP (mg/L)	43.63±52.97	26.9±42	<.0001
WBC count	11123±10726	9856±5180	.05
Creat clear (mL/min)	72±34	78±32	.01
Ht (%)	41.4±5.4	41.4±5.0	.93
LDL (mg/dL)	125.36±46.33	127.23±44.6	.59
Prior statin therapy (% hyperlipidemics)	44	42	.21
Current smoking %	49	47	.49
Physical activity (%)	58	66	.30
Hypertension (%)	59	62	.36
Receiving medication for hypertension (%)	41	49	.32
Diabetes mellitus (%)	36	30	.13
Receiving oral medication for diabetes mellitus (%)	31	36	.08
Insulin therapy (%)	30	33	.18

LVSD indicates left ventricular systolic dysfunction; BMI indicates body mass index; Ht indicates hematocrit; Time delay = time in minutes from symptoms onset till hospitalization; Previous CHD: previous known coronary heart disease.